Feb 27 (Reuters) - Xbrane Biopharma AB:
* Reports positive in-vitro biosimilarity data on Xlucane
* Study demonstrates no significant difference of Xlucane versus reference product on most important parameters Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
Our Standards: The Thomson Reuters Trust Principles.